BAP31, a promising target for the immunotherapy of malignant melanomas

PURPOSE: Malignant melanoma’s (MM) incidence is rising faster than that of any other cancer in the US and the overall survival at 5 years is less than 10%. B cell associated protein 31 (BAP31) is overexpressed in most MMs and might be a promising target for immunotherapy of this disease. EXPERIMENTA...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Exp Clin Cancer Res
Asıl Yazarlar: Yu, Shaojuan, Wang, Fuli, Fan, Li, Wei, Yuying, Li, Haitao, Sun, Yuanjie, Yang, Angang, Jin, Boquan, Song, Chaojun, Yang, Kun
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2015
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4405826/
https://ncbi.nlm.nih.gov/pubmed/25903101
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-015-0153-6
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller